Recombinant allergens

References

• Pajno GB, Barberio G, De Luca F, Morabito L, Parmiani S. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy 2001; 31:1392 - 7; http://dx.doi.org/10.1046/j.1365-2222.2001.01161.x; PMID: 11591189
   PubMed Web of Science ®Google Scholar
• Jacobsen L, Niggemann B, Dreborg S, Ferdousi HA, Halken S, Høst A, et al, The PAT investigator group. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 2007; 62:943 - 8; http://dx.doi.org/10.1111/j.1398-9995.2007.01451.x; PMID: 17620073
   PubMed Web of Science ®Google Scholar
• Jutel M, Akdis CA. Immunological mechanisms of allergen-specific immunotherapy. Allergy 2011; 66:725 - 32; http://dx.doi.org/10.1111/j.1398-9995.2011.02589.x; PMID: 21466562
   PubMed Web of Science ®Google Scholar
• Akdis CA, Akdis M. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol 2011; 127:18 - 27, quiz 28-9; http://dx.doi.org/10.1016/j.jaci.2010.11.030; PMID: 21211639
   PubMed Web of Science ®Google Scholar
• Noon L. Prophylactic inoculation against hay fever. Lancet 1911; 177:1572 - 3; http://dx.doi.org/10.1016/S0140-6736(00)78276-6
   Google Scholar
• Ring J, Gutermuth J. 100 years of hyposensitization: history of allergen-specific immunotherapy (ASIT). Allergy 2011; 66:713 - 24; http://dx.doi.org/10.1111/j.1398-9995.2010.02541.x; PMID: 21320133
   PubMed Web of Science ®Google Scholar
• Grönlund H, Vrtala S, Wiedermann U, Dekan G, Kraft D, Valenta R, et al. Carbohydrate-based particles: a new adjuvant for allergen-specific immunotherapy. Immunology 2002; 107:523 - 9; http://dx.doi.org/10.1046/j.1365-2567.2002.01535.x; PMID: 12460198
   PubMed Web of Science ®Google Scholar
• Ibarrola I, Sanz ML, Gamboa PM, Mir A, Benahmed D, Ferrer A, et al. Biological characterization of glutaraldehyde-modified Parietaria judaica pollen extracts. Clin Exp Allergy 2004; 34:303 - 9; http://dx.doi.org/10.1111/j.1365-2222.2004.01859.x; PMID: 14987312
   PubMed Web of Science ®Google Scholar
• Marsh DG, Norman PS, Roebber M, Lichtenstein LM. Studies on allergoids from naturally occurring allergens. III. Preparation of ragweed pollen allergoids by aldehyde modification in two steps. J Allergy Clin Immunol 1981; 68:449 - 59; http://dx.doi.org/10.1016/0091-6749(81)90199-8; PMID: 6171586
   PubMed Web of Science ®Google Scholar
• Cox L. Standardized allergen extracts: past, present and future. Expert Rev Clin Immunol 2005; 1:579 - 88; http://dx.doi.org/10.1586/1744666X.1.4.579; PMID: 20477599
   PubMedGoogle Scholar
• Aalberse RC, Crameri R. IgE-binding epitopes: a reappraisal. Allergy 2011; 66:1261 - 74; http://dx.doi.org/10.1111/j.1398-9995.2011.02656.x; PMID: 21623828
   PubMed Web of Science ®Google Scholar
• Casale TB, Stokes JR. Future forms of immunotherapy. J Allergy Clin Immunol 2011; 127:8 - 15, quiz 16-7; http://dx.doi.org/10.1016/j.jaci.2010.10.034; PMID: 21094518
   PubMed Web of Science ®Google Scholar
• Bohle B, Breitwieser A, Zwölfer B, Jahn-Schmid B, Sára M, Sleytr UB, et al. A novel approach to specific allergy treatment: the recombinant fusion protein of a bacterial cell surface (S-layer) protein and the major birch pollen allergen Bet v 1 (rSbsC-Bet v 1) combines reduced allergenicity with immunomodulating capacity. J Immunol 2004; 172:6642 - 8; PMID: 15153479
   PubMed Web of Science ®Google Scholar
• Moldaver D, Larché M. Immunotherapy with peptides. Allergy 2011; 66:784 - 91; http://dx.doi.org/10.1111/j.1398-9995.2011.02610.x; PMID: 21507007
   PubMed Web of Science ®Google Scholar
• Zeiler T, Taivainen A, Rytkönen M, Rautiainen J, Karjalainen H, Mäntyjärvi R, et al. Recombinant allergen fragments as candidate preparations for allergen immunotherapy. J Allergy Clin Immunol 1997; 100:721 - 7; http://dx.doi.org/10.1016/S0091-6749(97)70264-1; PMID: 9438477
   PubMed Web of Science ®Google Scholar
• Valenta R, Niespodziana K, Focke-Tejkl M, Marth K, Huber H, Neubauer A, et al. Recombinant allergens: what does the future hold?. J Allergy Clin Immunol 2011; 127:860 - 4; http://dx.doi.org/10.1016/j.jaci.2011.02.016; PMID: 21458656
   PubMed Web of Science ®Google Scholar
• Jutel M, Jaeger L, Suck R, Meyer H, Fiebig H, Cromwell O. Allergen-specific immunotherapy with recombinant grass pollen allergens. J Allergy Clin Immunol 2005; 116:608 - 13; http://dx.doi.org/10.1016/j.jaci.2005.06.004; PMID: 16159631
   PubMed Web of Science ®Google Scholar
• Young RA, Davis RW. Yeast RNA polymerase II genes: isolation with antibody probes. Science 1983; 222:778 - 82; http://dx.doi.org/10.1126/science.6356359; PMID: 6356359
   PubMed Web of Science ®Google Scholar
• Thomas WR. The advent of recombinant allergens and allergen cloning. J Allergy Clin Immunol 2011; 127:855 - 9; http://dx.doi.org/10.1016/j.jaci.2010.12.1084; PMID: 21251702
   PubMed Web of Science ®Google Scholar
• Chua KY, Stewart GA, Thomas WR, Simpson RJ, Dilworth RJ, Plozza TM, et al. Sequence analysis of cDNA coding for a major house dust mite allergen, Der p 1. Homology with cysteine proteases. J Exp Med 1988; 167:175 - 82; http://dx.doi.org/10.1084/jem.167.1.175; PMID: 3335830
   PubMed Web of Science ®Google Scholar
• Thomas WR, Stewart GA, Simpson RJ, Chua KY, Plozza TM, Dilworth RJ, et al. Cloning and expression of DNA coding for the major house dust mite allergen Der p 1 in Escherichia coli. Int Arch Allergy Appl Immunol 1988; 85:127 - 9; http://dx.doi.org/10.1159/000234488; PMID: 3276629
   PubMedGoogle Scholar
• Fang KS, Vitale M, Fehlner P, King TP. cDNA cloning and primary structure of a white-face hornet venom allergen, antigen 5. Proc Natl Acad Sci U S A 1988; 85:895 - 9; http://dx.doi.org/10.1073/pnas.85.3.895; PMID: 3422469
   PubMed Web of Science ®Google Scholar
• Weber E, Hunter S, Stedman K, Dreitz S, Olivry T, Hillier A, et al. Identification, characterization, and cloning of a complementary DNA encoding a 60-kd house dust mite allergen (Der f 18) for human beings and dogs. J Allergy Clin Immunol 2003; 112:79 - 86; http://dx.doi.org/10.1067/mai.2003.1602; PMID: 12847483
   PubMed Web of Science ®Google Scholar
• Thomas WR, Hales BJ, Smith WA. House dust mite allergens in asthma and allergy. Trends Mol Med 2010; 16:321 - 8; http://dx.doi.org/10.1016/j.molmed.2010.04.008; PMID: 20605742
   PubMed Web of Science ®Google Scholar
• Valenta R, Lidholm J, Niederberger V, Hayek B, Kraft D, Grönlund H. The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT). Clin Exp Allergy 1999; 29:896 - 904; http://dx.doi.org/10.1046/j.1365-2222.1999.00653.x; PMID: 10383589
   PubMed Web of Science ®Google Scholar
• Knol EF, Knulst AC. Application of multiplexed immunoglobulin E determination on a chip in component-resolved diagnostics in allergy. Clin Exp Allergy 2010; 40:190 - 2; http://dx.doi.org/10.1111/j.1365-2222.2009.03402.x; PMID: 19912247
   PubMed Web of Science ®Google Scholar
• Uermösi C, Beerli RR, Bauer M, Manolova V, Dietmeier K, Buser RB, et al. Mechanisms of allergen-specific desensitization. J Allergy Clin Immunol 2010; 126:375 - 83; http://dx.doi.org/10.1016/j.jaci.2010.05.040; PMID: 20624641
   PubMed Web of Science ®Google Scholar
• Jahn-Schmid B, Sirven P, Leb V, Pickl WF, Fischer GF, Gadermaier G, et al. Characterization of HLA class II/peptide-TCR interactions of the immunodominant T cell epitope in Art v 1, the major mugwort pollen allergen. J Immunol 2008; 181:3636 - 42; PMID: 18714038
   PubMed Web of Science ®Google Scholar
• Ebner C, Szépfalusi Z, Ferreira F, Jilek A, Valenta R, Parronchi P, et al. Identification of multiple T cell epitopes on Bet v I, the major birch pollen allergen, using specific T cell clones and overlapping peptides. J Immunol 1993; 150:1047 - 54; PMID: 7678615
   PubMed Web of Science ®Google Scholar
• Westritschnig K, Horak F, Swoboda I, Balic N, Spitzauer S, Kundi M, et al. Different allergenic activity of grass pollen allergens revealed by skin testing. Eur J Clin Invest 2008; 38:260 - 7; http://dx.doi.org/10.1111/j.1365-2362.2008.01938.x; PMID: 18339006
   PubMed Web of Science ®Google Scholar
• Thomas WR, Smith WA, Hales BJ, Mills KL, O’Brien RM. Characterization and immunobiology of house dust mite allergens. Int Arch Allergy Immunol 2002; 129:1 - 18; http://dx.doi.org/10.1159/000065179; PMID: 12372994
   PubMed Web of Science ®Google Scholar
• Egger M, Mutschlechner S, Wopfner N, Gadermaier G, Briza P, Ferreira F. Pollen-food syndromes associated with weed pollinosis: an update from the molecular point of view. Allergy 2006; 61:461 - 76; http://dx.doi.org/10.1111/j.1398-9995.2006.00994.x; PMID: 16512809
   PubMed Web of Science ®Google Scholar
• Gamboa PM, Sánchez-Monge R, Díaz-Perales A, Salcedo G, Ansótegui J, Sanz ML. Latex-vegetable syndrome due to custard apple and aubergine: new variations of the hevein symphony. J Investig Allergol Clin Immunol 2005; 15:308 - 11; PMID: 16433216
   PubMed Web of Science ®Google Scholar
• Blanco C. Latex-fruit syndrome. Curr Allergy Asthma Rep 2003; 3:47 - 53; http://dx.doi.org/10.1007/s11882-003-0012-y; PMID: 12542994
   PubMed Web of Science ®Google Scholar
• Sidenius KE, Hallas TE, Poulsen LK, Mosbech H. Allergen cross-reactivity between house-dust mites and other invertebrates. Allergy 2001; 56:723 - 33; http://dx.doi.org/10.1034/j.1398-9995.2001.056008723.x; PMID: 11488665
   PubMed Web of Science ®Google Scholar
• Hauser M, Roulias A, Ferreira F, Egger M. Panallergens and their impact on the allergic patient. Allergy Asthma Clin Immunol 2010; 6:1; http://dx.doi.org/10.1186/1710-1492-6-1; PMID: 20298513
   PubMedGoogle Scholar
• Skamstrup Hansen K, Poulsen LK. Component resolved testing for allergic sensitization. Curr Allergy Asthma Rep 2010; 10:340 - 8; http://dx.doi.org/10.1007/s11882-010-0133-z; PMID: 20628838
   PubMed Web of Science ®Google Scholar
• Weber RW. Cross-reactivity of pollen allergens: impact on allergen immunotherapy. Ann Allergy Asthma Immunol 2007; 99:203-11; quiz 12-3, 31.
   Google Scholar
• Hiller R, Laffer S, Harwanegg C, Huber M, Schmidt WM, Twardosz A, et al. Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment. FASEB J 2002; 16:414 - 6; PMID: 11790727
   PubMed Web of Science ®Google Scholar
• Purohit A, Niederberger V, Kronqvist M, Horak F, Grönneberg R, Suck R, et al. Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives. Clin Exp Allergy 2008; 38:1514 - 25; http://dx.doi.org/10.1111/j.1365-2222.2008.03042.x; PMID: 18564326
   PubMed Web of Science ®Google Scholar
• Linhart B, Hartl A, Jahn-Schmid B, Verdino P, Keller W, Krauth MT, et al. A hybrid molecule resembling the epitope spectrum of grass pollen for allergy vaccination. J Allergy Clin Immunol 2005; 115:1010 - 6; http://dx.doi.org/10.1016/j.jaci.2004.12.1142; PMID: 15867859
   PubMed Web of Science ®Google Scholar
• Pauli G, Purohit A, Oster JP, De Blay F, Vrtala S, Niederberger V, et al. Comparison of genetically engineered hypoallergenic rBet v 1 derivatives with rBet v 1 wild-type by skin prick and intradermal testing: results obtained in a French population. Clin Exp Allergy 2000; 30:1076 - 84; http://dx.doi.org/10.1046/j.1365-2222.2000.00869.x; PMID: 10931114
   PubMed Web of Science ®Google Scholar
• Niederberger V, Horak F, Vrtala S, Spitzauer S, Krauth MT, Valent P, et al. Vaccination with genetically engineered allergens prevents progression of allergic disease. Proc Natl Acad Sci U S A 2004; 101:Suppl 2 14677 - 82; http://dx.doi.org/10.1073/pnas.0404735101; PMID: 15310844
   PubMed Web of Science ®Google Scholar
• Reisinger J, Horak F, Pauli G, van Hage M, Cromwell O, König F, et al. Allergen-specific nasal IgG antibodies induced by vaccination with genetically modified allergens are associated with reduced nasal allergen sensitivity. J Allergy Clin Immunol 2005; 116:347 - 54; http://dx.doi.org/10.1016/j.jaci.2005.04.003; PMID: 16083789
   PubMed Web of Science ®Google Scholar
• Niederberger V, Reisinger J, Valent P, Krauth MT, Pauli G, van Hage M, et al. Vaccination with genetically modified birch pollen allergens: immune and clinical effects on oral allergy syndrome. J Allergy Clin Immunol 2007; 119:1013 - 6; http://dx.doi.org/10.1016/j.jaci.2006.12.661; PMID: 17292956
   PubMed Web of Science ®Google Scholar
• Pree I, Reisinger J, Focke M, Vrtala S, Pauli G, van Hage M, et al. Analysis of epitope-specific immune responses induced by vaccination with structurally folded and unfolded recombinant Bet v 1 allergen derivatives in man. J Immunol 2007; 179:5309 - 16; PMID: 17911617
   PubMed Web of Science ®Google Scholar
• Pauli G, Larsen TH, Rak S, Horak F, Pastorello E, Valenta R, et al. Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis. J Allergy Clin Immunol 2008; 122:951 - 60; http://dx.doi.org/10.1016/j.jaci.2008.09.017; PMID: 19000581
   PubMed Web of Science ®Google Scholar
• Winther L, Poulsen L, Robin B, Melac M, Malling H. Safety and Tolerability of Recombinant Bet v 1 (rBet v 1) tablets in sublingual immunotherapy (SLIT). J Allergy Clin Immunol 2009; 123:suppl S215; http://dx.doi.org/10.1016/j.jaci.2008.12.822
   Google Scholar
• Valenta R, Linhart B, Swoboda I, Niederberger V. Recombinant allergens for allergen-specific immunotherapy: 10 years anniversary of immunotherapy with recombinant allergens. Allergy 2011; 66:775 - 83; http://dx.doi.org/10.1111/j.1398-9995.2011.02565.x; PMID: 21352238
   PubMed Web of Science ®Google Scholar
• Larché M. Peptide and recombinant immunotherapy. [xi.] Immunol Allergy Clin North Am 2011; 31:377 - 89, xi; http://dx.doi.org/10.1016/j.iac.2011.03.008; PMID: 21530826
   PubMed Web of Science ®Google Scholar
• Moldaver D, Larché M. Immunotherapy with peptides. Allergy 2011; 66:784 - 91; http://dx.doi.org/10.1111/j.1398-9995.2011.02610.x; PMID: 21507007
   PubMed Web of Science ®Google Scholar
• Kündig TM, Senti G, Schnetzler G, Wolf C, Prinz Vavricka BM, Fulurija A, et al. Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults. J Allergy Clin Immunol 2006; 117:1470 - 6; http://dx.doi.org/10.1016/j.jaci.2006.01.040; PMID: 16751015
   PubMed Web of Science ®Google Scholar
• Larché M. Peptide immunotherapy for allergic diseases. Allergy 2007; 62:325 - 31; http://dx.doi.org/10.1111/j.1398-9995.2006.01309.x; PMID: 17298351
   PubMed Web of Science ®Google Scholar
• Simons FE, Imada M, Li Y, Watson WT, HayGlass KT. Fel d 1 peptides: effect on skin tests and cytokine synthesis in cat-allergic human subjects. Int Immunol 1996; 8:1937 - 45; http://dx.doi.org/10.1093/intimm/8.12.1937; PMID: 8982778
   PubMed Web of Science ®Google Scholar
• Norman PS, Ohman JL Jr., Long AA, Creticos PS, Gefter MA, Shaked Z, et al. Treatment of cat allergy with T-cell reactive peptides. Am J Respir Crit Care Med 1996; 154:1623 - 8; PMID: 8970345
   PubMed Web of Science ®Google Scholar
• Maguire P, Nicodemus C, Robinson D, Aaronson D, Umetsu DT. The safety and efficacy of ALLERVAX CAT in cat allergic patients. Clin Immunol 1999; 93:222 - 31; http://dx.doi.org/10.1006/clim.1999.4795; PMID: 10600332
   PubMed Web of Science ®Google Scholar
• Haselden BM, Kay AB, Larché M. Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions. J Exp Med 1999; 189:1885 - 94; http://dx.doi.org/10.1084/jem.189.12.1885; PMID: 10377184
   PubMed Web of Science ®Google Scholar
• Haselden BM, Larché M, Meng Q, Shirley K, Dworski R, Kaplan AP, et al. Late asthmatic reactions provoked by intradermal injection of T-cell peptide epitopes are not associated with bronchial mucosal infiltration of eosinophils or T(H)2-type cells or with elevated concentrations of histamine or eicosanoids in bronchoalveolar fluid. J Allergy Clin Immunol 2001; 108:394 - 401; http://dx.doi.org/10.1067/mai.2001.117460; PMID: 11544459
   PubMed Web of Science ®Google Scholar
• Oldfield WL, Kay AB, Larché M. Allergen-derived T cell peptide-induced late asthmatic reactions precede the induction of antigen-specific hyporesponsiveness in atopic allergic asthmatic subjects. J Immunol 2001; 167:1734 - 9; PMID: 11466398
   PubMed Web of Science ®Google Scholar
• Oldfield WL, Larché M, Kay AB. Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial. Lancet 2002; 360:47 - 53; http://dx.doi.org/10.1016/S0140-6736(02)09332-7; PMID: 12114041
   PubMed Web of Science ®Google Scholar
• Alexander C, Ying S, B Kay A, Larché M. Fel d 1-derived T cell peptide therapy induces recruitment of CD4+ CD25+; CD4+ interferon-gamma+ T helper type 1 cells to sites of allergen-induced late-phase skin reactions in cat-allergic subjects. Clin Exp Allergy 2005; 35:52 - 8; http://dx.doi.org/10.1111/j.1365-2222.2005.02143.x; PMID: 15649266
   PubMed Web of Science ®Google Scholar
• Alexander C, Tarzi M, Larché M, Kay AB. The effect of Fel d 1-derived T-cell peptides on upper and lower airway outcome measurements in cat-allergic subjects. Allergy 2005; 60:1269 - 74; http://dx.doi.org/10.1111/j.1398-9995.2005.00885.x; PMID: 16134993
   PubMed Web of Science ®Google Scholar
• Müller U, Akdis CA, Fricker M, Akdis M, Blesken T, Bettens F, et al. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. J Allergy Clin Immunol 1998; 101:747 - 54; http://dx.doi.org/10.1016/S0091-6749(98)70402-6; PMID: 9648701
   PubMed Web of Science ®Google Scholar
• Fellrath JM, Kettner A, Dufour N, Frigerio C, Schneeberger D, Leimgruber A, et al. Allergen-specific T-cell tolerance induction with allergen-derived long synthetic peptides: results of a phase I trial. J Allergy Clin Immunol 2003; 111:854 - 61; http://dx.doi.org/10.1067/mai.2003.1337; PMID: 12704369
   PubMed Web of Science ®Google Scholar
• Tarzi M, Klunker S, Texier C, Verhoef A, Stapel SO, Akdis CA, et al. Induction of interleukin-10 and suppressor of cytokine signalling-3 gene expression following peptide immunotherapy. Clin Exp Allergy 2006; 36:465 - 74; http://dx.doi.org/10.1111/j.1365-2222.2006.02469.x; PMID: 16630151
   PubMed Web of Science ®Google Scholar
• Crameri R, Kündig TM, Akdis CA. Modular antigen-translocation as a novel vaccine strategy for allergen-specific immunotherapy. Curr Opin Allergy Clin Immunol 2009; 9:568 - 73; http://dx.doi.org/10.1097/ACI.0b013e3283310fdf; PMID: 19680120
   PubMed Web of Science ®Google Scholar
• Martínez-Gómez JM, Johansen P, Rose H, Steiner M, Senti G, Rhyner C, et al. Targeting the MHC class II pathway of antigen presentation enhances immunogenicity and safety of allergen immunotherapy. Allergy 2009; 64:172 - 8; http://dx.doi.org/10.1111/j.1398-9995.2008.01812.x; PMID: 19076537
   PubMed Web of Science ®Google Scholar
• Zaleska A, Soyer O, Eiwegger T, Bassin C, Sollner S, Palomares O, et al. Immune regulation by intralymphatic immunotherapy with modular allergen-translocation MAT vaccine. Allergy 2011; 66:1 - 104
   Google Scholar
• Focke M, Linhart B, Hartl A, Wiedermann U, Sperr WR, Valent P, et al. Non-anaphylactic surface-exposed peptides of the major birch pollen allergen, Bet v 1, for preventive vaccination. Clin Exp Allergy 2004; 34:1525 - 33; http://dx.doi.org/10.1111/j.1365-2222.2004.02081.x; PMID: 15479266
   PubMed Web of Science ®Google Scholar
• Saarne T, Neimert-Andersson T, Grönlund H, Jutel M, Gafvelin G, van Hage M. Treatment with a Fel d 1 hypoallergen reduces allergic responses in a mouse model for cat allergy. Allergy 2011; 66:255 - 63; http://dx.doi.org/10.1111/j.1398-9995.2010.02468.x; PMID: 20804464
   PubMed Web of Science ®Google Scholar
• Niespodziana K, Focke-Tejkl M, Linhart B, Civaj V, Blatt K, Valent P, van Hage M, Gronlund H, Valenta R. A hypoallergenic cat vaccine based on Fel d 1-derived peptides fused to hepatitis B PreS. J Allergy Clin Immunol 2011; 127:1562-70 e6.
   Google Scholar
• Valenta R, Niespodziana K, Focke-Tejkl M, Marth K, Huber H, Neubauer A, et al. Recombinant allergens: what does the future hold?. J Allergy Clin Immunol 2011; 127:860 - 4; http://dx.doi.org/10.1016/j.jaci.2011.02.016; PMID: 21458656
   PubMed Web of Science ®Google Scholar